Direct determination of verapamil in urine and serum samples by micellar liquid chromatography and fluorescence detection

被引:36
作者
Rambla-Alegre, M. [1 ]
Gil-Agusti, M. T. [1 ]
Capella-Peiro, M. E. [1 ]
Carda-Broch, S. [1 ]
Esteve-Romero, J. S. [1 ]
机构
[1] Univ Jaume 1, ESTCE, CCEE, Area Quim Analit, Castellon de La Plana 12080, Spain
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 839卷 / 1-2期
关键词
verapamil; micellar mobile phase; direct injection; serum; urine;
D O I
10.1016/j.jchromb.2006.03.054
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Verapamil, a calcium channel antagonist, is one of the most commonly prescribed drugs in the treatment of hypertension. In this work, it was determined in serum and urine samples by a sensitive and precise chromatographic procedure without any pre-treatment step in a C-18 column using a micellar mobile phase of 0.15 M sodium dodecyl sulfate and 5% pentanol at pH 7. Fluorescence detection set at 230 nm (excitation) and 312 nm (emission) was used. Verapamil is eluted at 12.5 min with no interference by the protein band or endogenous compounds. Linearities (r > 0.998), as well as intra- and inter-day precision, were studied in the validation of the method. LODs were also calculated to be 11.0, 18.5 and 20.2 ng/mL in micellar solution, serum and urine, respectively. Recoveries in the biological matrices were in the 97-99% range. Drug excretion in urine was studied in a volunteer receiving treatment for hypertension, and verapamil, as an unchanged drug, was separated from other metabolites. The procedure developed can be useful in the field of toxicology and clinical analysis. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 20 条
[1]  
*AM HOSP FORM SERV, 1988, DRUG INF
[2]  
[Anonymous], 2001, Guidance for Industry-bioanalytical method validation
[3]   Accuracy of calculated pH-dependent aqueous drug solubility [J].
Bergström, CAS ;
Luthman, K ;
Artursson, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (05) :387-398
[4]   Achiral and chiral high-performance liquid chromatography of verapamil and its metabolites in serum samples [J].
Brandsteterová, E ;
Wainer, IW .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 732 (02) :395-404
[5]   Determination in serum of some barbiturates using micellar liquid chromatography with direct injection [J].
Capella-Peiró, ME ;
Gil-Agustí, M ;
Martinavarro-Domínguez, A ;
Esteve-Romero, J .
ANALYTICAL BIOCHEMISTRY, 2002, 309 (02) :261-268
[6]   Micellar liquid chromatography for the determination of drug materials in pharmaceutical preparations and biological samples [J].
Esteve-Romero, J ;
Carda-Broch, S ;
Gil-Agustí, M ;
Capella-Peiró, ME ;
Bose, D .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2005, 24 (02) :75-91
[7]   TREATMENT OF VERAPAMIL TOXICITY IN INTACT DOGS [J].
GAY, R ;
ALGEO, S ;
LEE, R ;
OLAJOS, M ;
MORKIN, E ;
GOLDMAN, S .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1805-1811
[8]   Determination of some banned stimulants in sports by micellar liquid chromatography [J].
Gil-Agustí, M ;
Capella-Peiró, ME ;
Martinaavarro-Domínguez, A ;
Esteve-Romero, J .
CHROMATOGRAPHIA, 2003, 57 (1-2) :51-57
[9]   Simultaneous first-order and capacity-limited elimination kinetics after oral administration of verapamil [J].
Gupta, SK ;
Hwang, S ;
Atkinson, L ;
Longstreth, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (01) :25-34
[10]   VERAPAMIL INTOXICATION - A LITERATURE-REVIEW OF OVERDOSES AND DISCUSSION OF THERAPEUTIC OPTIONS [J].
HOFER, CA ;
SMITH, JK ;
TENHOLDER, MF .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (04) :431-438